Jan 11, 2021 9:00am EST CohBar Announces Preclinical Collaboration with NIAID to Evaluate Potential of CB5064 Analogs for Treatment of COVID-19 ARDS
Dec 09, 2020 9:00am EST CohBar Confirms Efficacy of Novel Apelin Agonists in Acute Respiratory Distress Syndrome (ARDS) Model
Nov 16, 2020 4:01pm EST CohBar Reports Third Quarter 2020 Financial Results and Provides Business Update
Nov 02, 2020 9:00am EST CohBar to Announce 2020 Third Quarter Financial Results and Provide Business Update on November 16, 2020
Oct 29, 2020 9:00am EDT CohBar to Host Key Opinion Leader Meeting on Antifibrotic Peptides for the Potential Treatment of Idiopathic Pulmonary Fibrosis
Oct 27, 2020 9:00am EDT CohBar to Participate at ROTH Capital COVID-19 Therapeutics in Development Event
Oct 26, 2020 9:00am EDT CohBar Antifibrotic Peptide in Combination with Nintedanib Shows Enhanced Effects in an Idiopathic Pulmonary Fibrosis Model